Screening for transcription factors and their regulatory small molecules involved in regulating the functions of CL1-5 cancer cells under the effects of macrophage-conditioned medium

Xue,Dongbo; Lu,Ming; Gao,Bo; Qiao,Xin; Zhang,Yingmei

doi:10.3892/or.2013.2937

Screening for transcription factors and their regulatory small molecules involved in regulating the functions of CL1-5 cancer cells under the effects of macrophage-conditioned medium

Authors:
- Dongbo Xue
- Ming Lu
- Bo Gao
- Xin Qiao
- Yingmei Zhang
View Affiliations

Affiliations: Department of Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Surgery, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA, Central Laboratory, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: December 20, 2013 https://doi.org/10.3892/or.2013.2937
Pages: 1323-1333

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Many reports have inferred that macrophages can interact with tumor cells in the tumor microenvironment (TME) in a vicious cycle of tumor development; however, the changes in gene expression in tumor cells under the effects of macrophages are still largely unknown. The present study was carried out to illustrate the changes in the gene expression profile in lung cancer cells under the effects of macrophage-conditioned medium. Gene expression profile data were derived from the GEO database GSE9315. The GSM234968 sample was derived from a highly invasive human pulmonary adenocarcinoma cell line, CL1-5, and was treated with conditioned medium (supernatant of a culture solution of human monocyte THP-1). The GSM234967 sample that was not treated with the conditioned medium was used as a control. GO and KEGG enrichment analyses were carried out using DAVID software, and visualization networks were constructed using Cytoscape software. The results showed that 40 differentially expressed genes were annotated. Five differentially expressed transcription factors were identified, EIF2B4, EIF2B5, JUNB, GNG11 and HMGB2, which were all related to ‘stress’ and ‘responses’. The gene cluster of JUNB was mainly enriched in cancer-related pathways, ‘Wnt signaling pathway’ and ‘MAPK signaling pathway’. Finally, 10 small molecules, thioridazine, resveratrol, astemizole, ciclopirox, calmidazolium, etoposide, anisomycin, pyrvinium, azacyclonol and terfenadine, which may act on transcription factors, were identified using the CMap database. In conclusion, we identified transcription factors playing key roles in tumor cells under the effects of macrophages in order to provide new clues for blocking this vicious cycle of tumor development.

View Figures

View References

1	Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today. 13:265–270. 1992. View Article : Google Scholar : PubMed/NCBI
2	Hildenbrand R and Schaaf A: The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Int J Oncol. 34:15–23. 2009.PubMed/NCBI
3	Lewis CE and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
4	Gentleman RC, Carey VJ, Bates DM, et al: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R802004. View Article : Google Scholar : PubMed/NCBI
5	Purohit V, Rapaka R, Kwon OS and Song BJ: Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma. Life Sci. 92:3–9. 2013. View Article : Google Scholar : PubMed/NCBI
6	Heuff G, Oldenburg HS, Boutkan H, et al: Enhanced tumor growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother. 37:125–130. 1993. View Article : Google Scholar : PubMed/NCBI
7	Chen JJ, Lin YC, Yao PL, et al: Tumor-associated macrophages: the double-edged sword in cancer progression. J Clin Oncol. 23:953–964. 2005. View Article : Google Scholar : PubMed/NCBI
8	Goetze K, Walenta S, Ksiazkiewicz M, Kunz-Schughart LA and Mueller-Klieser W: Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. Int J Oncol. 39:453–463. 2011.PubMed/NCBI
9	De Palma M and Lewis CE: Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell. 23:277–286. 2013.PubMed/NCBI
10	Horton LW, Yu Y, Zaja-Milatovic S, Strieter RM and Richmond A: Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. Cancer Res. 67:9791–9799. 2007. View Article : Google Scholar : PubMed/NCBI
11	Smith HA and Kang Y: The metastasis-promoting roles of tumor-associated immune cells. J Mol Med. 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sawant A, Hensel JA, Chanda D, et al: Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol. 189:4258–4265. 2012. View Article : Google Scholar : PubMed/NCBI
13	White ES, Strom SR, Wys NL and Arenberg DA: Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J Immunol. 166:7549–7555. 2001. View Article : Google Scholar : PubMed/NCBI
14	Lin EY, Li JF, Gnatovskiy L, et al: Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66:11238–11246. 2006. View Article : Google Scholar : PubMed/NCBI
15	Lin EY, Nguyen AV, Russell RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
16	Hagemann T, Robinson SC, Schulz M, et al: Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-α dependent up-regulation of matrix metalloproteases. Carcinogenesis. 25:1543–1549. 2004.PubMed/NCBI
17	Andrecht S, Kolbus A, Hartenstein B, Angel P and Schorpp-Kistner M: Cell cycle promoting activity of JunB through cyclin A activation. J Biol Chem. 277:35961–35968. 2002. View Article : Google Scholar : PubMed/NCBI
18	Schmidt D, Textor B, Pein OT, et al: Critical role for NF-κB-induced JunB in VEGF regulation and tumor angiogenesis. EMBO J. 26:710–719. 2007.
19	Nausch N, Florin L, Hartenstein B, et al: Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1ɛ. J Immunol. 176:7–11. 2006.PubMed/NCBI
20	Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, et al: Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol. 170:356–365. 2007. View Article : Google Scholar
21	Pulukuri SM and Rao JS: Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. Int J Oncol. 32:757–765. 2008.PubMed/NCBI
22	Xu D, McKee CM, Cao Y, et al: Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res. 70:6988–6998. 2010. View Article : Google Scholar : PubMed/NCBI
23	Kawaguchi-Ihara N, Murohashi I, Nara N and Tohda S: Promotion of the self-renewal capacity of human acute leukemia cells by Wnt3A. Anticancer Res. 28:2701–2704. 2008.PubMed/NCBI
24	Hu J, Dong A, Fernandez-Ruiz V, et al: Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma. Cancer Res. 69:6951–6959. 2009. View Article : Google Scholar : PubMed/NCBI
25	Kim D, Rath O, Kolch W and Cho KH: A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways. Oncogene. 26:4571–4579. 2007. View Article : Google Scholar : PubMed/NCBI
26	Jeong AY, Lee MY, Lee SH, Park JH and Han HJ: PPARδ agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/β-catenin. Cell Cycle. 8:611–619. 2009.
27	Gazitt Y, Kolaparthi V, Moncada K, Thomas C and Freeman J: Targeted therapy of human osteosarcoma with 17AAG or rapamycin: Characterization of induced apoptosis and inhibition of mTOR and Akt/MAPK/Wnt pathways. Int J Oncol. 34:551–561. 2009.PubMed/NCBI
28	Samara KD, Antoniou KM, Karagiannis K, et al: Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol. 40:1397–1404. 2012.PubMed/NCBI
29	Tanaka J, Sugimoto K, Shiraki K, et al: Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas. Int J Oncol. 37:805–814. 2010.PubMed/NCBI
30	Takala H, Kauppila JH, Soini Y, et al: Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun. 3:631–638. 2011. View Article : Google Scholar : PubMed/NCBI
31	Qiu J, Shao S, Yang G, Shen Z and Zhang Y: Association of Toll like receptor 9 expression with lymph node metastasis in human breast cancer. Neoplasma. 58:251–255. 2011. View Article : Google Scholar : PubMed/NCBI
32	Lotze MT, Zeh HJ, Rubartelli A, et al: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev. 220:60–81. 2007. View Article : Google Scholar : PubMed/NCBI
33	Sato Y, Goto Y, Narita N and Hoon DS: Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron. 2(Suppl 1): 205–214. 2009. View Article : Google Scholar : PubMed/NCBI
34	Ikebe M, Kitaura Y, Nakamura M, et al: Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J Surg Oncol. 100:725–731. 2009. View Article : Google Scholar : PubMed/NCBI
35	Agha-Mohammadi S and Lotze MT: Immunomodulation of cancer: potential use of selectively replicating agents. J Clin Invest. 105:1173–1176. 2000. View Article : Google Scholar : PubMed/NCBI
36	Tsai JP, Chen HW, Cheng ML, et al: Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-β1 and interleukin-6 in the development of in situ tumor immunity. Immunobiology. 210:661–671. 2005.PubMed/NCBI
37	Barbieri G, Rimini E and Costa MA: Effects of human leukocyte antigen (HLA)-DR engagement on melanoma cells. Int J Oncol. 38:1589–1595. 2011.PubMed/NCBI
38	König R, Stertz S, Zhou Y, et al: Human host factors required for influenza virus replication. Nature. 463:813–817. 2010.PubMed/NCBI
39	Chen MH, Lin KJ, Yang WL, et al: Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer. 119:293–303. 2013. View Article : Google Scholar : PubMed/NCBI
40	Wei G, Twomey D, Lamb J, et al: Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell. 10:331–342. 2006. View Article : Google Scholar : PubMed/NCBI